Pantoprazole Gastro Resistant & Levosulpiride Sustained Release Capsules – Zentro LS Capsules

ZENTRO LS Capsules
Composition:- Pantoprazole Sodium (EC) 40 mg + Levosulpiride (SR) 75 mg.

ZENTRO LS – Pantoprazole Gastro-Resistant & Levosulpiride Sustained Release Capsules combination of Pantoprazole, a proton pump inhibitor (PPI), reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme, treats GERD, and aids in healing peptic ulcers and esophageal damage caused by excess acid and Levosulpiride, a prokinetic agent, provides dual action by reducing stomach acid and improving gastrointestinal motility. It is highly effective in managing acid reflux, gastritis, and functional dyspepsia.

Key Points of Pantoprazole Gastro Resistant & Levosulpiride Sustained Release Capsules – Zentro LS Capsules
• Dual Action Formula – Pantoprazole reduces stomach acid while Levosulpiride enhances gastric motility for better digestion
• Effective GERD Management – Provides relief from symptoms associated with GERD like acid reflux, heartburn, and regurgitation
• Improves Gastric Healing – Helps heal peptic and gastric ulcers by reducing acid secretion, and Levosulpiride’s prokinetic action helps manage nausea associated with acid reflux.

Can be Prescribed by:
• Gastroenterologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.